The Future of Intraoperative Pathology
Real-time, gold-standard margin assessment, without labels, slides, or delays
The Future of Intraoperative Pathology
Real-time, gold-standard margin assessment, without labels, slides, or delays
About NIO Path
Precision Pathology, From the Inside Out
NIO Path is an early-stage medical technology company focused on transforming intraoperative cancer care. Our mission is to enable real-time, high-fidelity tumor margin assessment directly in the OR, eliminating delays and reducing the need for repeat surgeries. Founded by experts in AI and photoacoustic imaging, we are building a new path for surgical precision.